全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:




Go

Minimising oncological treatment of early breast cancer

J Yarnold

Three-dimensional mammography

MJ Yaffe

Introduction to proton (H) magnetic resonance spectroscopy of the breast

L Bartella

Ultrasound-guided axillary node core biopsy in the staging of newly diagnosed breast cancer

P Britton, A Goud, S Barter, A Eleti, A Freeman, M Gaskarth, P Moyle, P Rajan, R Sinnatamby, J Slattery, E Provenzano, S Pinder, S Godward, G Wishart

Contrast enhanced and dual energy mammography

MJ Yaffe

Identification of personal risk of breast cancer: genetics

Diana M Eccles

Positron emission tomography in breast disease

B Sharma

Prognosis of small screen-detected invasive breast cancers

I Ellis

Molecular diversity of human breast cancer: clinical and therapeutic implications

D Slamon

A novel role for C-terminal binding proteins in the regulation of mitotic fidelity in breast cancer cells

LM Bergman, CN Birts, M Darley, B Gabrielli, JP Blaydes

Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival

H McKeen, C Byrne, A Valentine, M O'Rourke, A Yakkundi, K McClelland, K McAlpine, DG Hirst, T Robson

Interactions between BRCA2 protein and the meiosis-specific recombinase DMC1

T Thorslund, F Esashi, SC West

Lineage commitment in mammary epithelium is regulated by type 2 cytokines and Stat6

WT Khaled, SE Nicholson, FO Baxter, N Sprigg, JP Stingl, ANJ McKenzie, CJ Watson

Chromosome translocations in breast cancer

K Howarth, K Blood, B Ng, J Beavis, Y Chua, S Cooke, J Pole, S Chin, K Ichimura, VP Collins, I Ellis, C Caldas, N Carter, PAW Edwards

Chromosomal instability in the pathogenesis and treatment of breast cancer

A Venkitaraman

Surviving breast cancer: can women expect to 'get back to normal'?

P Hopwood

Controversies in Breast Cancer 2008

William R Miller

ESR1 and EGF genetic variation in relation to breast cancer risk and survival

Kristjana Einarsdóttir, Hatef Darabi, Yi Li, Yen Low, Yu Li, Carine Bonnard, Arvid Sj？lander, Kamila Czene, Sara Wedrén, Edison T Liu, Per Hall, Keith Humphreys, Jianjun Liu

PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes

Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica CM Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

Andrea Sassen, Justine Rochon, Peter Wild, Arndt Hartmann, Ferdinand Hofstaedter, Stephan Schwarz, Gero Brockhoff

Breast cancer tumor growth estimated through mammography screening data

Harald Weedon-Fekj？r, Bo H Lindqvist, Lars J Vatten, Odd O Aalen, Steinar Tretli

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas

Christina Magkou, Lydia Nakopoulou, Christina Zoubouli, Kanelina Karali, Irene Theohari, Panagiotis Bakarakos, Ioanna Giannopoulou

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk

Sascha Abbas, Alexandra Nieters, Jakob Linseisen, Tracy Slanger, Silke Kropp, Elke Mutschelknauss, Dieter Flesch-Janys, Jenny Chang-Claude

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study

Gretchen L Gierach, James V Lacey, Arthur Schatzkin, Michael F Leitzmann, Douglas Richesson, Albert R Hollenbeck, Louise A Brinton

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

Andrew E Teschendorff, Carlos Caldas

Intrauterine environments and breast cancer risk: meta-analysis and systematic review

Sue Park, Daehee Kang, Katherine A McGlynn, Montserrat Garcia-Closas, Yeonju Kim, Keun Yoo, Louise A Brinton

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer

Aparna Mitra, Rebecca A Fillmore, Brandon J Metge, Mathur Rajesh, Yaguang Xi, Judy King, Jingfang Ju, Lewis Pannell, Lalita A Shevde, Rajeev S Samant

Local control by radiotherapy: is that all there is?

Silvia C Formenti, Sandra Demaria

A functional Notch–survivin gene signature in basal breast cancer

Connie W Lee, Karl Simin, Qin Liu, Janet Plescia, Minakshi Guha, Ashraf Khan, Chung-Cheng Hsieh, Dario C Altieri

A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis

Patrick Neven, Toon Van Gorp, Karen Deraedt

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Joan S Lewis-Wambi, Helen R Kim, Chris Wambi, Roshani Patel, Jennifer R Pyle, Andres J Klein-Szanto, V Craig Jordan

Correction: BCoR-L1 variation and breast cancer

Felicity Lose, Jeremy Arnold, David B Young, Carolyn J Brown, Graham J Mann, Gulietta M Pupo, The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Kum Khanna, Georgia Chenevix-Trench, Amanda B Spurdle

Breast cancer stem cells: implications for therapy of breast cancer

Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds, J Alejandro Lopez

Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II

Heather Feigelson, Lauren R Teras, W Ryan Diver, Weining Tang, Alpa V Patel, Victoria L Stevens, Eugenia E Calle, Michael J Thun, Mark Bouzyk

Regulation of cancer stem cells by p53

D Joseph Jerry, Luwei Tao, Haoheng Yan

Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study

Bernard Rosner, Graham A Colditz, J Dirk Iglehart, Susan E Hankinson

Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

Giuseppe Cancello, Emilia Montagna, Diego D'Agostino, Mario Giuliano, Antonio Giordano, Giuseppe Di Lorenzo, Monica Plaitano, Sabino De Placido, Michele De Laurentiis

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

Nuran Bektas, Erik Noetzel, Jürgen Veeck, Michael F Press, Glen Kristiansen, Amjad Naami, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, Ruth Knüchel, Peter A Fasching, Edgar Dahl

Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer

Shirly Davidovich, Ofer Ben-Izhak, Ma'anit Shapira, Boris Futerman, Dan D Hershko

Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers

Christina Yau, Christopher C Benz

Identification and mechanisms of endocrine resistance

William R Miller

Ultrasound elastography

G Rizzatto

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy

V Craig Jordan, Roshani Patel, Joan S Lewis-Wambi, Ramona F Swaby

Integration of endocrine therapy with targeted agents

Stephen RD Johnston

Ultra-small iron particle-enhanced magnetic resonance imaging of axillary lymph nodes in breast cancer

TH Helbiech

Markers of endocrine sensitivity

Daniel F Hayes

Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells

Yuchao Gu, Junhua Zhang, Wenyi Mi, Jing Yang, Feng Han, Xinzhi Lu, Wengong Yu

CADET 2 results/computer-aided detection update

F Gilbert

Promoting early presentation of breast cancer

AJ Ramirez

Magnetic resonance imaging in breast cancer: results of the COMICE trial

L Turnbull

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705